title: Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study.
abstract: Acquired immunodeficiency syndrome (AIDS) is a systemic illness affecting multiple organs, including the heart. Left ventricular (LV) diastolic dysfunction has been reported as the first echocardiographically detectable abnormality in several cardiovascular disorders. We tested the hypothesis that Human Immunodeficiency Virus (HIV) carriers have LV diastolic impairment when studied early in the clinical course of the infection. Doppler echocardiographic and computerized time-motion parameters of LV diastolic function were obtained in 51 HIV patients and in 25 age- and sex-matched healthy controls. The HIV population consisted of 28 totally asymptomatic subjects and 23 patients with incipient AIDS. As compared to controls, the HIV group had similar heart rate, blood pressure level, LV dimensions and fractional shortening, but increased isovolumetric relaxation time (P = 0.03), early filling duration (P < 0.001) and decreased early mitral flow peak velocity (E) (P = 0.02) and EF slope (P < 0.001). HIV patients also showed lower values for posterior wall thinning (PWT, P < 0.01) and peak lengthening velocity of the posterior wall (PVL, P < 0.05), and a trend to a decreased peak rate of LV enlargement in diastole (D+, P = 0.05). Doppler-derived parameters of diastolic function were significantly altered in the asymptomatic HIV group vs controls. The LV diastolic indices were similar in symptomatic and asymptomatic HIV patients except for PWT, which was lower in the symptomatic HIV group (P = 0.04). Since mild and focal wall motion abnormalities were detected in 11 HIV carriers (22%), comparison of LV diastolic indexes between HIV patients and controls was also performed in two subgroups; these included asymptomatic (n = 26) and symptomatic (n = 14) patients with normal contractile state. The two subgroups had abnormalities of diastolic function similar to those of the HIV group as a whole, but with somewhat lower levels of statistical significance. Our data strongly suggest that there is myocardial involvement at the early stage of HIV infection; however, its impact on the clinical course of the disease remains to be clarified.
authors.affiliation: Inserm U275, Loa-Ensta-Ecole Polytechnique, Palaiseau, France.
authors.forename: N
authors.initials: N
authors.lastname: Coudray
authors.forename: D
authors.initials: D
authors.lastname: de Zuttere
authors.forename: G
authors.initials: G
authors.lastname: Force
authors.forename: D
authors.initials: D
authors.lastname: Champetier de Ribes
authors.forename: J C
authors.initials: JC
authors.lastname: Pourny
authors.forename: I
authors.initials: I
authors.lastname: Antony
authors.forename: Y
authors.initials: Y
authors.lastname: Lecarpentier
authors.forename: D
authors.initials: D
authors.lastname: Chemla
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000503:physiopathology*; D000328:Adult; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D015658:HIV Infections / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000502:physiology*; D011446:Prospective Studies; D015203:Reproducibility of Results; D012815:Signal Processing, Computer-Assisted; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology*